
Gagana Mallawaarachchi
Articles
-
Nov 18, 2024 |
jnnp.bmj.com | Joyutpal Das |Gagana Mallawaarachchi |Jack Grimshaw |Thomas Jackson
Contributors Planning: JD and DR; Conduct: JD and DR and Reporting: all authors. Responsible for the overall content as the guarantor: JD.
-
Jun 5, 2024 |
jnnp.bmj.com | Joyutpal Das |Jack Grimshaw |Thomas Jackson |Gagana Mallawaarachchi
AbstractBackground A growing body of evidence suggests inequitable access to disease-modifying therapies (DMTs) for multiple sclerosis (MS) in publicly funded healthcare systems. This retrospective study examined the impact of ethnicity and deprivation on the access to DMTs.Methods All adults diagnosed with relapsing-remitting MS between 2010 and 2020 were included.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →